Academic literature on the topic 'Antineoplastic agents Safety measures'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antineoplastic agents Safety measures.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Antineoplastic agents Safety measures"
Griggs, Jennifer J., Kari Bohlke, Edward P. Balaban, James J. Dignam, Evan T. Hall, R. Donald Harvey, Diane P. Hecht, et al. "Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update." Journal of Clinical Oncology 39, no. 18 (June 20, 2021): 2037–48. http://dx.doi.org/10.1200/jco.21.00471.
Full textSilva, Trajano Felipe Barrabas Xavier da, Humberto Costa, and Marcelo Montebello Ribeiro. "Chemical risks that nurses are exposed in antineoplastic therapy services in a hospital setting: a systematic review protocol." Scientific Electronic Archives 14, no. 3 (February 26, 2021): 112–15. http://dx.doi.org/10.36560/14320211304.
Full textBenhabib, Amine, Saïd Ioughlissen, Christelle Ratignier-Carbonneil, and Patrick Maison. "The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study." BMJ Open 10, no. 3 (March 2020): e034033. http://dx.doi.org/10.1136/bmjopen-2019-034033.
Full textHealy, Regan, Deborah Passey, Derek Pinnell, Joshua Qualls, Clayton Hamilton, Zach Burningham, Elizabeth Tilley, Tanya Hood, Brian C. Sauer, and Ahmad Sami Halwani. "Veterans on anticancer medications in rural and community environment support (VA CARES) program: A pharmacist-led telemedicine medication management program for veterans receiving oral antineoplastic therapies through the MISSION Act." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 1545. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.1545.
Full textGraeve, Catherine Utecht, Patricia Marie McGovern, Bruce Alexander, Timothy Church, Andrew Ryan, and Martha Polovich. "Occupational Exposure to Antineoplastic Agents." Workplace Health & Safety 65, no. 1 (October 7, 2016): 9–20. http://dx.doi.org/10.1177/2165079916662660.
Full textBrana, Irene, Geoffrey Shapiro, Melissa Lynne Johnson, Helena Alexandra Yu, Debbie Robbrecht, Daniel Shao-Weng Tan, Lillian L. Siu, et al. "Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 3005. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3005.
Full textSewell, Graham J. "Pharmaceutical issues: preparation and handling." Journal of Oncology Pharmacy Practice 1, no. 1_suppl (May 1995): 6–12. http://dx.doi.org/10.1177/1078155295001001s03.
Full textKruse, R. H., W. H. Puckett, and J. H. Richardson. "Biological safety cabinetry." Clinical Microbiology Reviews 4, no. 2 (April 1991): 207–41. http://dx.doi.org/10.1128/cmr.4.2.207.
Full textVucicevic, Jelica, Katarina Nikolic, and John B. O. Mitchell. "Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches." Current Medicinal Chemistry 26, no. 21 (September 19, 2019): 3874–89. http://dx.doi.org/10.2174/0929867324666170712115411.
Full textPassamonti, Francesco, Martin Griesshammer, Michele Cavo, Miklos Egyed, Giulia Benevolo, Timothy Devos, Jeannie Callum, et al. "Demographics, Baseline Characteristics, and Disease Symptom Burden in RESPONSE-2: A Randomized, Phase 3 Study of Ruxolitinib in Polycythemia Vera Patients (pts) Who Are Resistant to or Intolerant of Hydroxyurea (HU)." Blood 126, no. 23 (December 3, 2015): 2807. http://dx.doi.org/10.1182/blood.v126.23.2807.2807.
Full textDissertations / Theses on the topic "Antineoplastic agents Safety measures"
Bolognesi, Natasha. "The media management of Nevirapine: content, causes and consequences." Thesis, Stellenbosch : University of Stellenbosch, 2006. http://hdl.handle.net/10019.1/2616.
Full textThis study presents an observation, analysis and effect indication of the media portrayal of the antiretroviral drug nevirapine in Western Cape daily newspapers. The research is aimed at ascertaining the quality and consequences of science reporting on an essential, yet too often politically controversial, AIDS treatment within the South African context. This work ultimately offers suggestions as to how the media could play a more beneficial role for the South African public when reporting on nevirapine and HIV/AIDS treatment in general.
Ashley, L. J., R. Dexter, F. Marshall, B. McKenzie, M. Ryan, and Gerry R. Armitage. "Improving the safety of chemotherapy administration: an oncology nurse-led failure mode and effects analysis." 2011. http://hdl.handle.net/10454/6792.
Full textPURPOSE/OBJECTIVES: To assess and improve the safety of hospital-based adult chemotherapy administration. DESIGN: Prospective, systems-focused clinical risk assessment. SETTING: An adult inpatient and outpatient oncology unit in a large urban hospital in the United Kingdom. SAMPLE: 8-person nurse-led multidisciplinary team, which included managerial staff and patient safety researchers. METHODS: Failure mode and effects analysis (FMEA), a prospective, systems-focused risk assessment methodology, was undertaken in biweekly team meetings and included mapping the chemotherapy administration process, identifying and numerically prioritizing potential errors (failure modes) for each process step, and generating remedial strategies to counteract them. MAIN RESEARCH VARIABLES: The analysis aimed to identify chemotherapy administration failure modes and to generate remedial strategies to address them. User feedback on the FMEA process also was collected. FINDINGS: Several specific chemotherapy failure modes were identified, the majority of which had not previously been recognized, and several novel strategies to counteract them were generated. Many of the strategies were specific, environment-focused actions, which are simple, quick, and inexpensive to implement; however, more substantive, longer-term initiatives also were generated. User feedback generally was very positive, and the process of undertaking the analysis improved multidisciplinary teamwork and communication. CONCLUSIONS: Although time and resource intensive, FMEA is a useful safety improvement tool. IMPLICATIONS FOR NURSING: Nurses should be aware of and informed about FMEA as a tool they can use in partnership with management and other disciplines to proactively and collectively improve the safety of high-risk oncology procedures such as chemotherapy administration.
Tang, Bo. "Pedestrian Protection Using the Integration of V2V Communication and Pedestrian Automatic Emergency Braking System." Thesis, 2015. http://hdl.handle.net/1805/10057.
Full textThe Pedestrian Automatic Emergency Braking System (PAEB) can utilize on-board sensors to detect pedestrians and take safety related actions. However, PAEB system only benefits the individual vehicle and the pedestrians detected by its PAEB. Additionally, due to the range limitations of PAEB sensors and speed limitations of sensory data processing, PAEB system often cannot detect or do not have sufficient time to respond to a potential crash with pedestrians. For further improving pedestrian safety, we proposed the idea for integrating the complimentary capabilities of V2V and PAEB (V2V-PAEB), which allows the vehicles to share the information of pedestrians detected by PAEB system in the V2V network. So a V2V-PAEB enabled vehicle uses not only its on-board sensors of the PAEB system, but also the received V2V messages from other vehicles to detect potential collisions with pedestrians and make better safety related decisions. In this thesis, we discussed the architecture and the information processing stages of the V2V-PAEB system. In addition, a comprehensive Matlab/Simulink based simulation model of the V2V-PAEB system is also developed in PreScan simulation environment. The simulation result shows that this simulation model works properly and the V2V-PAEB system can improve pedestrian safety significantly.
Books on the topic "Antineoplastic agents Safety measures"
Safety and health handbook for cytotoxic drugs. Lanham: Government Institutes, 2011.
Find full textGuidelines for the safe administration of cytotoxic medical preparations in the treatment of patients with cancer. Dublin: Stationery Office, 1996.
Find full textInternational Conference on Anticarcinogenesis and Radiation Protection (3rd 1989 Dubrovnik, Croatia). Anticarcinogenesis and radiation protection 2. New York: Plenum Press, 1991.
Find full textHewitt, Jeanne Beauchamp. Health effects of occupational exposure to antineoplastic drugs: An integrative research review. Toronto: Occupational Disease Panel, Ministry of Labour, 1997.
Find full textChris, Hartley. Health and safety : hazardous agents. [Wigston]: IOSH Services Ltd, 2003.
Find full textSen, A. K. Defence against chemical and biological agents. New Delhi: Defence Research and Development Organisation, Ministry of Defence, 2009.
Find full textK, Sen A. Defence against chemical and biological agents. New Delhi: Defence Research and Development Organisation, Ministry of Defence, 2009.
Find full textDefence Research & Development Organisation (India), ed. Defence against chemical and biological agents. New Delhi: Defence Research and Development Organisation, Ministry of Defence, 2009.
Find full textKanal, Emanuel. Safety manual on magnetic resonance imaging contrast agents. Cedar Knolls, N.J: Lippincott-Raven Healthcare, 1995.
Find full textIvanov, S. I. Obespechenie bezopasnŏ ėkspluatat͡sii truboprovodov, transportiruiushchikh serovodosoderzhashchie sredy =: Providing safe explotation of pipelines intended for transporting hydrogen sulfide-containing agents. Moskva: Nedra, 2006.
Find full textBook chapters on the topic "Antineoplastic agents Safety measures"
Hell, Wolfram, Kurt Bodewig, Ute Hammer, Christian Kellner, Clemens Klinke, Matthias Mück, Martin Schreiner, Felix Walz, and Guido Zielke. "Vision Zero in Germany." In The Vision Zero Handbook, 1–21. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-23176-7_13-1.
Full textHell, Wolfram, Kurt Bodewig, Ute Hammer, Christian Kellner, Clemens Klinke, Matthias Mück, Martin Schreiner, Felix Walz, and Guido Zielke. "Vision Zero in Germany." In The Vision Zero Handbook, 337–57. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-76505-7_13.
Full text"Genotoxic assessment in different exposure groups working with antineoplastic agents." In Occupational Safety and Hygiene III, 189–92. CRC Press, 2015. http://dx.doi.org/10.1201/b18042-37.
Full textVerhoeven, Didier, Etienne Brain, François Duhoux, Gilberto Schwartsmann, and Fatima Cardoso. "Systemic Therapy." In Breast cancer: Global quality care, edited by Hans Junkermann, Wolfgang Buchberger, Sylvia Heywang-Köbrunner, Michael Michell, Alexander Mundinger, Carol Benn, and Sophia Zackrisson, 176–93. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198839248.003.0016.
Full textSamundeeswari, E. S., and F. Mary Magdalene Jane. "Mobile Code and Security Issues." In Web Services Security and E-Business, 75–92. IGI Global, 2007. http://dx.doi.org/10.4018/978-1-59904-168-1.ch004.
Full textSamundeeswari, E. S., and F. Mary Magdalene Jane. "Mobile Code and Security Issues." In Mobile Computing, 2568–82. IGI Global, 2009. http://dx.doi.org/10.4018/978-1-60566-054-7.ch196.
Full textSamundeeswari, E. S., and F. Mary Magdalene Jane. "Mobile Code and Security Issues." In Electronic Business, 2183–97. IGI Global, 2009. http://dx.doi.org/10.4018/978-1-60566-056-1.ch135.
Full textSamundeeswari, E. S., and F. Mary Magdalene Jane. "Mobile Code and Security Issues." In Mobile and Ubiquitous Commerce, 256–69. IGI Global, 2009. http://dx.doi.org/10.4018/978-1-60566-366-1.ch014.
Full textWilliam Tong, C. Y. "Biosafety Categorisations and Containment Levels." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0021.
Full textMizielińska, Małgorzata, and Artur Bartkowiak. "Overview of Food Antimicrobial Packaging." In Food Preservation and Packaging - Recent Process and Technological Advancements [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.108666.
Full textConference papers on the topic "Antineoplastic agents Safety measures"
Roberts, H. R. "PREVENTION OF DEEP VENOUS THROMBOSIS: CONCLUSIONS OF A CONSENSUS DEVELOPMENT CONFERENCE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642966.
Full textWang, Yingying, Fangqiu Li, Menglan Duan, Houfa Liu, and Jiandong Gu. "Reliability Modelling of Subsea Cluster Manifolds Based on the Fault Tree Analysis." In ASME 2016 35th International Conference on Ocean, Offshore and Arctic Engineering. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/omae2016-54396.
Full textKretzschmar, Florian, Matthias Beggiato, and Alois Pichler. "Detection of Discomfort in Autonomous Driving via Stochastic Approximation." In 13th International Conference on Applied Human Factors and Ergonomics (AHFE 2022). AHFE International, 2022. http://dx.doi.org/10.54941/ahfe1002437.
Full text